DATa Rich Clinical Trials (DART) - Work Package 12
Research type
Research Study
Full title
User experience study of digital tools to collect data on wellbeing and side effects in cancer patients
IRAS ID
333333
Contact name
Helen White
Contact email
Sponsor organisation
Netherlands Cancer Institute (NKI) on behalf of Cancer Core Europe (CCE)
Duration of Study in the UK
1 years, 0 months, 16 days
Research summary
This is a feasibility, non-CTIMP study (within the Cancer Core Europe Data Rich Clinical Trials project), designed to evaluate whether patients receiving anticancer treatment in phase 1 or 2 anticancer drug trials, executed in Cancer Core Europe Centres, will use digital applications to record Health Related Quality of Life data. It will conduct an assessment of the uptake of the tool, the compliance to schedule and the quality of the data collected. Additionally, it aims to better understand the experience of patients and healthcare professionals in the use of digital tools to collect clinical data on well-being and adverse events. The study will be conducted alongside the patient’s standard care and will not interfere in their trial-specific treatment.
REC name
South West - Cornwall & Plymouth Research Ethics Committee
REC reference
24/SW/0146
Date of REC Opinion
19 Dec 2024
REC opinion
Further Information Favourable Opinion